journal article·2016-02Open access

Magnetically Driven Silver‐Coated Nanocoils for Efficient Bacterial Contact Killing

Marcus Hoop, Yang Shen, Xiang‐Zhong Chen, Fajer Mushtaq, Loredana M. Iuliano, Mahmut S. Sakar, Andrew Petruska, Martin J. Loessner, Bradley J. Nelson, Salvador Pané

Advanced Functional Materials· Volume 26· Issue 7

Abstract

The increasing threat of multidrug‐resistant bacterial strains against conventional antibiotic therapies represents a significant worldwide health risk and intensifies the need for novel antibacterial treatments. In this work, an effective strategy to target and kill bacteria using silver‐coated magnetic nanocoils is reported. The coil palladium (Pd) nanostructures are obtained by electrodeposition and selective dealloying, and subsequently coated with nickel (Ni) and silver (Ag) for magnetic manipulation and antibacterial properties, respectively. The efficiency of the nanocoils is tested in the treatment of Gram‐negative Escherichia coli (E. coli) and Gram‐positive methicillin‐resistant Staphylococcus aureus (S. aureus), both of which represent the leading multidrug‐resistant bacterial pathogens. The nanocoils show highly effective bacterial killing activity at low concentrations and in relatively short durations of treatment time. Three different investigation techniques, LIVE/DEAD assay, colony‐forming unit counting, and scanning electron microscope, reveal that the antibacterial activity is a result of bacterial membrane damage caused by direct contact with the nanocoil. The low cytotoxicity toward fibroblast cells along with the capability of precise magnetic locomotion makes the proposed nanocoil an ideal candidate to combat multidrug‐resistant bacteria in the field of biomedical and environmental applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Robotics and Intelligent Systems (IRIS) ETH Zurich Tannenstrasse 3 CH‐8092 Zurich Switzerland

Institute of Food, Nutrition and Health ETH Zurich Schmelzbergstrasse 7 CH‐8092 Zurich Switzerland

Funding

European Research Council Starting Grant · ERC

References (56)

Show source-provided references
1. 10.1128/MMBR.00016-1010.1128/MMBR.00016-10 ↗
2. 10.1038/nchembio.2007.2410.1038/nchembio.2007.24 ↗
3. CDC. Antibiotic resistance threats in the United States 2013 http://www.cdc.gov/drugresistance/threat‐report‐2013/pdf/ar‐threats‐2013‐508.pdf(accessed: May 14 2015).
4. 10.1038/nrmicro233310.1038/nrmicro2333 ↗
5. 10.1038/nchem.101210.1038/nchem.1012 ↗
6. 10.1038/jid.2012.39910.1038/jid.2012.399 ↗
7. 10.1038/nm114510.1038/nm1145 ↗
8. 10.1038/nrd220210.1038/nrd2202 ↗
9. 10.1016/S1357-4310(00)01815-310.1016/S1357-4310(00)01815-3 ↗
10. 10.2217/17435889.3.3.32910.2217/17435889.3.3.329 ↗
11. 10.1128/AAC.00163-0710.1128/AAC.00163-07 ↗
12. 10.2174/18715260778210999810.2174/187152607782109998 ↗
13. 10.2147/IJN.S7615010.2147/IJN.S76150 ↗
14. 10.2217/17435889.2.6.77710.2217/17435889.2.6.777 ↗
15. 10.1021/mp400281610.1021/mp4002816 ↗
16. 10.1021/acsnano.5b0002110.1021/acsnano.5b00021 ↗
17. 10.1016/j.biotechadv.2008.09.00210.1016/j.biotechadv.2008.09.002 ↗
18. 10.1023/A:100925322305510.1023/A:1009253223055 ↗
19. 10.1007/s11051-010-9900-y10.1007/s11051-010-9900-y ↗
20. 10.1126/scitranslmed.300627610.1126/scitranslmed.3006276 ↗
21. 10.1016/j.nano.2007.02.00110.1016/j.nano.2007.02.001 ↗
22. 10.1002/anie.20120592310.1002/anie.201205923 ↗
23. 10.1021/ja411705d10.1021/ja411705d ↗
24. 10.1186/s40638-014-0001-810.1186/s40638-014-0001-8 ↗
25. 10.1002/adma.20140444410.1002/adma.201404444 ↗
26. 10.1128/CMR.00081-0910.1128/CMR.00081-09 ↗
27. 10.4103/0974-777X.5925110.4103/0974-777X.59251 ↗
28. 10.1039/C3NR04760A10.1039/C3NR04760A ↗
29. 10.1021/nl202332x10.1021/nl202332x ↗
30. Melber C. K. · 2002
31. 10.1007/s00253005145710.1007/s002530051457 ↗
32. 10.1021/ja402424j10.1021/ja402424j ↗
33. 10.1371/journal.pone.008598110.1371/journal.pone.0085981 ↗
34. 10.1080/08927014.2010.52700010.1080/08927014.2010.527000 ↗
35. Jones R. N. · 1985 · 972
36. 10.1128/AEM.02218-0610.1128/AEM.02218-06 ↗
37. 10.1128/AEM.02750-0610.1128/AEM.02750-06 ↗
38. 10.1021/bi050854210.1021/bi0508542 ↗
39. 10.1007/s00253-009-2159-510.1007/s00253-009-2159-5 ↗
40. 10.1021/cm100023p10.1021/cm100023p ↗
41. 10.1021/pr050407910.1021/pr0504079 ↗
42. 10.1039/c3tb21569e10.1039/c3tb21569e ↗
43. 10.1016/j.cell.2007.06.04910.1016/j.cell.2007.06.049 ↗
44. 10.1021/acsami.5b0362610.1021/acsami.5b03626 ↗
45. 10.1021/nn300042m10.1021/nn300042m ↗
46. 10.1088/0957-4484/16/10/05910.1088/0957-4484/16/10/059 ↗
47. 10.1128/JB.186.10.3254-3258.200410.1128/JB.186.10.3254-3258.2004 ↗
48. Magalhaes P. O. · J. Pharm. Pharm. Sci. · 2007 · 10 · 388
49. 10.1128/IAI.69.5.3423-3426.200110.1128/IAI.69.5.3423-3426.2001 ↗
50. 10.1021/nn901252r10.1021/nn901252r ↗
51. 10.1021/nn101390x10.1021/nn101390x ↗
52. 10.1039/C3NR04997C10.1039/C3NR04997C ↗
53. 10.1088/0957-4484/21/17/17510410.1088/0957-4484/21/17/175104 ↗
54. 10.1038/emi.2012.3510.1038/emi.2012.35 ↗
55. 10.1002/smll.20110182110.1002/smll.201101821 ↗
56. 10.1002/adma.20110381810.1002/adma.201103818 ↗